Jacobs John C 4
4 · NOVAVAX INC · Filed Jan 27, 2025
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Jacobs John C
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-01-23+83,196→ 130,722 total - Tax Payment
Common Stock
2025-01-23$9.55/sh−38,873$371,237→ 91,849 total - Exercise/Conversion
Restricted Stock Units
[F1]2025-01-23−83,196→ 83,197 totalExercise: $0.00Exp: 2033-01-23→ Common Stock (83,196 underlying)
Footnotes (1)
- [F1]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.
Signature
/s/Mark J. Casey, Attorney-in-Fact|2025-01-27